期刊文献+

卵巢过度刺激综合征的预测 被引量:4

Prediction of ovarian hyperstimulation syndrome
原文传递
导出
摘要 目的:探讨在辅助生育治疗过程中卵巢过度刺激综合征的诱因。方法:回顾性分析该院生殖中心2006年~2008年40例中重度OHSS患者的临床及实验室指标。结果:OHSS组窦卵泡数、E2水平、获卵数较非OHSS组增高,而体重指数、FSH用量小于非OHSS组,差异有统计学意义。BMI<22.5kg/m2、基础卵泡数≥19个、HCG日E2≥5000pg/ml及获卵数≥25个时易发生OHSS。结论:在促排卵过程中,根据体重指数、基础卵泡数、E2水平及获卵数临床可预测OHSS的发生。 Objective: To explore the inducing factors of ovarian hyperstimulation syndrome (OHSS) during assisted reproduction techniques therapy. Methods : Clinical data and experiment indexes of 40 cases with medium - severe OHSS from 2006 to 2008 were analysed retrospectively. Results : The number of baseline follicles, E2 level in serum and number of ooeytes per retrieval in OHSS group were higher than those in non - OHSS group, while BMI and FSH dose reversed. When BMI 〈 22. 5 kg/m^2 , number of baseline follicles≥ 19, E2 level in serum on HCG day ≥ 5 000 pg/ml and number of oocytes per retrieval≥25, OHSS occurred more easily. Conclusion: In the course of controlled ovarian stimulation, BMI, number of baseline follicles, E2 level in serum and number of ooeytes per retrieval are predictive indexes.
出处 《中国妇幼保健》 CAS 北大核心 2009年第19期2635-2637,共3页 Maternal and Child Health Care of China
关键词 卵巢过度刺激综合征 促排卵药物 辅助生育 Ovarian hyperstimulation syndrome Drugs for controlled ovarian stimulation Assisted reproduction techniques
  • 相关文献

参考文献5

  • 1Binder H, Dittrich R, Einhaus F et al. Update on ovarian hyperstimulation syndrome: Part Ⅰ - incidence and pathogenesis [ J] . Int J Fertil WomensMed, 2007, 52 (!): 11
  • 2Lu XE, Yang XF. Outcome of in vitro fertilization - embryo transfer in treatment of polycystic ovarian syndrome [J] . Zhejiang Da Xue Xue Bao Yi Xue Ban, 2006, 35 (3) : 319
  • 3曹云霞,周平.卵巢过度刺激综合征的诱发因素及其防治[J].中国实用妇科与产科杂志,2006,22(5):327-330. 被引量:6
  • 4Mocanu E, Redmond ML, Hennelly Bet al. Odds of ovarian hyperstimulation syndrome ( OHSS ) - time for reassessment[J] . Hum Fertil (Camb), 2007, 10 (3): 175
  • 5Lee TH, Liu CH, Huang CC et al. Serum anti - mullerian hormone and estradiol levels as predictors of ovarian hyperstimulation syndrome in assisted reproduction technology cycles [ J]. Hum Reprod, 2008, 23 (1): 160

二级参考文献12

  • 1章志国,魏兆莲,曹云霞,丛林,周平,赵济华,王艳玲,李芬.人成熟卵泡液在人未成熟卵母细胞体外培养中的应用[J].生殖医学杂志,2005,14(1):40-42. 被引量:12
  • 2Daya S.Updated meta-analysis of recombinant follicle-stimulating hormone (FSH) versus urinary FSH for ovarian stimulation in assisted reproduction[J].Fertil Steril,2002,77 (4):711 -714.
  • 3Whelan Ⅲ JG,Vlahos NF.The ovarian hyperstimulation syndrome[J].Fertil Steril,2002,73 (5):883-896.
  • 4AI-Inany H,Aboulghar M.GnRH antagonist in assisted reproduction:a cochrane review[J].Hum Reprod,2002,17 (4):874-885.
  • 5Griesinger G,Diedrich K,Devroey P,et al.GnRH agonist for triggering final oocyte maturation in the GnRH antagonist ovarian hyperstimulation protocol:a systematic review and meta-analysis[J].Hum Reprod Update,2005,10:451-456.
  • 6Shimon I,Rubinek T,Bar-Hava I,et al.Ovarian hyperstimulation without elevated serum estradiol associated with pure folliclestimulating hormone-secreting pituitary adenoma[J].J Clin Endocrinol Metab,2001,86(8):3635-3640.
  • 7Asch RH,Li HP,Balmaceda JP,et al.Severe ovarian hyperstimulation syndrome in assisted reproductive technology:definition of high risk groups[J].Hum Reprod,1991,6 (10):1395-1399.
  • 8Mansour R,Aboulghar M,Serour G,et al.Criteria of a successful coasting protocol for the prevention of severe ovarian hyperstimulation syndrome[J].Hum Reprod,2005,20 (11):3167-3172.
  • 9Lainas T,Petsas G,Stavropoulou G,et al.Administration of methylprednisolone to prevent severe ovarian hyperstimulation syndrome in patients undergoing in vitro fertilization[J].Fertil Steril,2002,78(3):529-533.
  • 10Fakih H,Bello S.Ovarian cyst aspiration:a therapeutic approach to ovarian hyperstimulation syndrome[J].Fertil Steril,1992,58(4):829-832.

共引文献5

同被引文献64

  • 1陈颖,郁琦,张以文,何方方,孙正怡.血清抑制素水平在体外受精-胚胎移植超排卵周期中预测卵巢反应性的价值[J].中华妇产科杂志,2006,41(6):368-371. 被引量:22
  • 2陈秋菊,孙晓溪,李路,高晓红,吴煜,程利南.控制性超排卵中卵巢高反应对体外受精-胚胎移植/卵胞浆内单精子注射周期妊娠结局的影响[J].生殖医学杂志,2007,16(1):7-11. 被引量:6
  • 3Swanton A, Storey L, Me Veigh E, et al. IVF outcome in womenwith PCOS, PCO and normal ovarian morphology. Eur JObstel Gynecol Reprod Riol, 2010,149(1):68-71.
  • 4The Rotterdam ESHRE/ASRM-sponsored PCOS ConsensusWorkshop Group. Revised 2003 consensus on diagnosticcriteria and long-term health risks related to polycystic ovarysyndrome (PCOS). Hum Reprod, 2004,19(1):41-7.
  • 5Cummins JM, Breen TM, Harrsion KL, et al. Aformula forscoring human embryo growth rates in in vitro fertilization:its value in predicting pregnancy and in comparison withvisual estimates of embryo quality. J in vitro Fertil EmbryoTransfer, 1986, 3(5):284-95.
  • 6Aramvit P, Pruksananonds K, Kasettratat N, et al. Risk factorsfor ovarian hyperstimulation syndrome in Thai patients us-ing gonadatropins for in vitro fertilization. Am J Health SystPharm, 2008, 65(2):1148-53.
  • 7Kahnberg A, Enskog A, Brannstrom M, et al. Prediction ofovarian hyperstimulation syndrome in women undergoing invitro fertilization. Acta Obstet Gyncol Scand, 2009,88(2):1371-81.
  • 8D,Angelo A.. Ovarian hyperstimulation syndrome preventionstrategies: cryopreservation of all embryos. Semin ReprodMed, 2010, 28(6):513-8.
  • 9Papanikolaou EG,Humaidan P,Polyzos N,et al.New algorithm for OHSS prevention[J].Reprod Biol Endocrinol,2011,3(9):147-153.
  • 10Swanton A,Storey L,McVeigh E,et al.IVF outcome in women with PCOS,PCO and normal ovarian morphology[J].Eur J Obstet Gynecol Reprod Biol,2010,149(1):68-71.

引证文献4

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部